A series of aminopropylindenes, designed as mimics of a cationic high energy intermediate in 
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Introduction
Sterol biosynthesis is a complex metabolic pathway in which two sharply different sections are well recognizable: an "assembly section" which is devoted to build the open triterpene 2,3-oxidosqualene starting from the common lipid precursor acetyl-CoA, and a "tailoring section" which remodels the sterol intermediates to generate the end-product (cholesterol, ergosterol or phytosterols, in animal, fungal or plant cells, respectively). The two sections are connected by the cyclization of 2,3-oxidosqualene, one of the most outstanding monoenzymatic reactions (if not the most one), that confers the steroid shape to the open triterpene oxidosqualene. This reaction is catalyzed by enzymes belonging to the family of oxidosqualene cyclases (OSC), which form lanosterol in non-photosynthetic organisms and, mostly, cycloartenol in photosynthetic organisms [1, 2] .
Cyclization of 2,3-oxidosqualene is triggered by the stereospecific protonation of the epoxide ring of the substrate and proceeds through the generation of several carbocationic high energy intermediates (HEIs) both during the formation of the new carbon-carbon bonds for the closure of the four rings-steroid scaffold (in the sequence pro-C4, C10, C8, C13 and C20) and during the rearrangement of the protosteryl carbocation pro-C20 (in the sequence pro-C17, C13, C14, and C8 or C9 depending on the product) till the removal of a proton and formation of lanosterol or cycloartenol. Studies for unravelling the above complex cyclization reaction had involved a number of laboratories for over fifty years, covering a complete list of expertises and methodologies, from chemical mimicking to protein purification, from inhibitory assays to site-directed mutagenesis [3] , till the crystallization of squalene and oxidosqualene cyclizing enzymes [4, 5, 6] .
Oxidosqualene cyclases have been considered attractive targets for designing cholesterol lowering [7] , antifungal [8, 9] , and antiparasitic agents [10, 11, 12] . Recently, inhibitors of oxidosqualene cyclase proved to be effective as anticancer agents against human cancer cells from various tissue origins [13] .
A common concept in the development of inhibitors of sterol (and other) biosynthesis is mimicking of the extremely short-lived carbocationic HEIs, most commonly accomplished by compounds having (a) a protonable aliphatic amino group, or (b) an aliphatic amine-N-oxide, or (c) a quaternary ammonium or pyridinium group at the pertinent position. The above molecule-designing strategy proved to be particularly prolific in designing inhibitors of OSC, being its reaction mechanism characterized by the consecutive formation of a number of carbocationic HEIs. Dozens of inhibitors have been synthesized during the last thirty years: (i) azadecalin and azasqualene derivatives [14] , (ii) Ro 48-8071 and related benzophenone derivatives designed by Roche [7, 15] and AstraZeneca groups [16] , (iii) pyridinium ion based inhibitors [9, 10, 17] , (iv) umbelliferone derivatives [18, 19] , (v) sulfur-containing analogues [20] , and others like BIBX 79 [21] (Fig. 1) .
Figure 1. Representative inhibitors of oxidosqualene cyclases (OSC).
In continuation of our previous work on the development of inhibitors of oxidosqualene cyclases from various organisms [12, 18, 19] and other enzymes in ergosterol [22] and cholesterol biosynthesis [23, 24, 25] we describe here a new chemotype of oxidosqualene cyclase inhibitors that was designed with the following rationale: in order to achieve high affinity to the enzymes, we introduced a homochiral equivalent of the rings C and D of sterols and the sterol side chain by using Grundmann's ketone (1) [26] as a building block. To this bicyclic scaffold we attached an aminopropyl chain, ending up with secosteroid-like molecules, in which the protonable nitrogen might mimic two of the early cationic HEIs of the cyclization cascade. Through free rotation of the aminopropyl chain the protonated amino group is able to occupy the position of the first occurring HEI at C-2 of the squalene chain (A; representing pro-C4 of the emerging sterol) as well as that of the pro-C10 HEI (B) (Figure 2 ). The newly designed molecules were assayed on five different OSCs, with the aim of identifying lead molecules for the development of new drugs. All the enzymes, namely lanosterol synthases from Saccharomyces cerevisiae, Pneumocystis carinii, Trypanosoma cruzi, and Homo sapiens, as well as the cycloartenol synthase from Arabidopsis thaliana, were expressed in an ERG7-deficient yeast (Saccharomyces cerevisiae) strain [27] . Cycloartenol synthase has been included in the present study in order to ascertain if the critical amino acid differences between lanosterol and cycloartenol synthases would influence their sensitivity to our inhibitors [28] .
In order to confirm activities of the inhibitors in a cellular system, selected compounds were assayed for their inhibition of total cholesterol biosynthesis in a human cell line [24] . Some of our new molecules proved to be highly effective and specific, and offer interesting clues to the development of new OSC inhibitors, especially as antiparasitic drugs.
Results and Discussion

Chemistry
Grundmann's ketone (also named Windaus ketone; 1) [26] was obtained in high yield by ozonolysis of cholecalciferol (vitamin D3), but by using a novel workup procedure (treatment of the ozonolysis mixture with water, followed by extraction with pentane). In this manner the well-documented epimerization of 1 at C-3a [29] could be avoided. The ketone was reacted with cyclopropylmagnesium bromide to give the tertiary alcohol 2. NMR and GC analysis of the crude product revealed that a mixture of epimers (putatively at C-3a and/or C-4) was formed. Since the stereocenters at both C-3a and C-4 were to be destroyed in the subsequent step, intermediate 2 was purified only superficially over a short silica column. Crude 2 was treated with hydrogen bromide in glacial acetic acid [30] to give the bromopropyl derivative 3 in high yield. The underlying homoallylic rearrangement led to a product with an endocyclic tetrasubstituted olefin, namely a product with only three, moreover configurationally stable asymmetric centers. Finally, reaction of 3 with primary and cyclic as well as acyclic secondary amines gave the desired aminopropylindene derivatives 4 -7. The piperidine substituent was selected since it might additionally mimic the ring A of the sterol, the N-allyl-N-methyl motif was selected, since it can be found in the benzophenone-type OSC inhibitor Ro-48-8071 ( Fig. 1) , which had recently been co-crystallized with human OSC and shown to bind to the enzyme in a manner like the pro-C-4 HEI A (Figure 2 ) does [5] . Since carbocationic HEIs can also be mimicked by tertiary amine N-oxides [31] and Nalkylpyridinium salts [9] , N-oxide 9 was prepared by oxidation of tertiary amine 6 with meta- 
Effect of inhibitors on OSCs from different organisms
Activity of the compounds as inhibitors of OSC was tested by incubating homogenates prepared from cell cultures of different recombinant yeast strains with radiolabelled 2,3-oxidosqualene in the presence of increasing inhibitor concentrations. A comparative determination of OSC inhibitory activity of the compounds on the recombinant enzymes revealed that compound 5, exclusively bearing a secondary amino group in the side-chain, was inactive on any OSC under investigation, while the remaining compounds showed both a strong structure-linked dependence and, other than the reference inhibitor Ro 48-8071, considerable differences in susceptibility among the enzymes from different organisms ( Table   1 ).
OSC from P. carinii revealed to be significantly inhibited only by 4, a molecule which on the other hand displayed comparably high activity on all assayed enzymes (IC50 range: 0.6-1.5 µM).
Among the target enzymes, cycloartenol synthase from the plant A. thaliana appeared to be the most sensitive to the inhibitors, with IC50 values ≤1 µM for five of the six compounds assayed (Table 1) . Inhibitors, which bear bulky piperidine and pyridinium rings show the most distinct selectivity for the cycloartenol synthase of A. thaliana. The oxidosqualene cyclases of the other species tested are more sensitive to inhibitors with small substituents at the nitrogen, and show no or only week inhibitory effects if bulky residues were chosen.
Interestingly, similar organism-dependent differences were observed in a previous study of ours [19] , in which a series of aminoalkyl umbelliferone derivatives were assayed on the same set of OSCs as in the present study. In that study, the most dramatic difference between plant and other OSCs was observed with a compound bearing a morpholine ring, which proved to be highly effective on the cyclase from A. thaliana, while resulted almost ineffective against the other OSCs. Pyridinium salt 8 showed negligible inhibition of T. cruzi OSC, what is in contrast to previous reports claiming that the significant antitrypanosomal activities of simple N-terpenyl pyridinium salts can be attributed to an inhibition of T. cruzi OSC [10] .
Comparison of the inhibitory effects of the N,N-dimethylamino compound 6 and the corresponding N-oxide 9 revealed that the tertiary amine showed higher activities on all
OSCs, but parallels in species selectivity are evident. This suggests that steric parameters might be crucial for species selectivity in this new chemotype of OSC inhibitors. Most interestingly, both the N,N-dimethylamino compound 6 and the N-oxide 9 show strong inhibition of T. cruzi OSC. In contrast to the reference inhibitor Ro 48-8071, however, these two compounds show considerable selectivity with respect to human OSC (factors ≥7), a property that is worth deeply exploring in designing new anti-trypanosomal agents. 
Assay for inhibition of cholesterol biosynthesis in cells
Compounds 4 and 6, which showed significant inhibition of human OSC in the in vitro screenings (Table 1) , were subjected to a whole cell assay on human HL-60 cells in order to investigate their activity at the cellular level. This assay is based on a method described by us previously [24] . The inhibitors were tested in triplicates at a concentration of 1 µM.
Incubation in the presence of 2-13 C-acetate leads to the incorporation of 13 C atoms into the cholesterol molecules biosynthesized during the incubation period, and allows us to distinguish newly synthesised cholesterol from unlabelled matrix cholesterol that was present in the cells before incubation, by GC-MS. At a fixed concentration of 1 µM 4 and 6 led to a decrease of overall cholesterol biosynthesis of >90% compared to untreated control samples.
At the same concentration Ro 48-8071 led to a decrease of >90%, for BIBX 79 a reduction of 60% was recorded.
Conclusion
This In a whole cell assay on a human cell line compounds 4 and 6 showed strong inhibition of total cholesterol biosynthesis, indicating that this class of inhibitors has proper physicochemical properties for being active in living cells.
The concept of combining a significant partial structure of the steroid backbone with functional groups which are able to mimic cationic high energy intermediates, is promising for further evaluation.
Experimental
Chemistry
Ozonolyses were performed on a Fisher Scientific 502 Ozon Generator (Fisher Scientific, All chemicals were purchased from Sigma Aldrich (Schnelldorf, Germany) and Acros
Organics (Geel, Belgium). Reactions were monitored by thin-layer chromatography (TLC) using pre-coated plastic sheets POLYGRAM SIL G/UV254 from Macherey-Nagel (Düren, Germany). Merck silica gel 60 was used as stationary phase for flash column chromatography (FCC).
The OSC substrate, 2,3-oxidosqualene (OS), was prepared as previously described [33] .
Labelled peptone, 2% glucose) supplemented with hemin (0.013 mg/mL) and ergosterol (0.02 mg/mL).
Hemin is needed in the medium as the SMY8 strains contain a mutation (hem1::TRP1) affecting the heme biosynthesis. The presence of a heme mutant background is necessary for the viability of lanosterol synthase mutants in aerobic conditions [36] . OSCs expression was and ergosterol (0.02 mg/mL). Human OSC expression was induced in SC-Ura medium with galactose (2%) in presence of hemin (0.013 mg/mL).
Enzyme assays
Cell-free homogenates were obtained as described [38] . Briefly, after lysis of the cell wall with lyticase, the spheroplasts were homogenized with a Potter device. Proteins in the homogenate were quantified with a protein assay kit (Sigma), based on the method of Lowry modified by Peterson [39] using bovine serum albumin as a standard.
OSC activity was assayed as described [38] . Briefly, the homogenates were incubated with Revelation 4.06) using the wavelength of 550 nm followed. The IC50-values were calculated by using Prism 4 (GraphPad Software, La Jolla, USA).
Assay for cholesterol biosynthesis inhibition
The whole cell assay for cholesterol biosynthesis inhibition was carried out on HL 60 cells as described by us previously [24] .
